Clinical trials: Apnea, Postanesthetic
Diabete Mellitus, Retina Vein Occlusion
Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab
Bevacizumab, an anti-VEGF (vascular endothelial growth factor) agent used in the treatment of diabetic retinopathy and macular edema associated with retinal vein occlusion, is commonly administered in ophthalmology clinics…
- Conditions
- Diabete Mellitus, Retina Vein Occlusion, Age Macular Degeneration
- Trial name
- NCT07550777
- Testing
- blood test
- Where
- Turkey (Türkiye)
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- Ataturk University
Butyrylcholinesterase Deficiency
Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
The purpose of this study is to investigate the safety and tolerability of AZD8848 in Butyrylcholinesterase deficient subjects in comparison with sex and age matched control subjects.
- Trial name
- NCT01205867
- Testing
- AZD8848
- Where
- Denmark
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- AstraZeneca
Biomarkers, Pharmacological
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
The primary objective of this study is to determine whether huperzine A, donepezil, and galantamine impact militarily relevant aspects of neurocognitive performance in humans, compared to placebo.
- Trial name
- NCT01194336
- Testing
- Huperzine A, Donepezil, Galantamine
- Where
- United States
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- U.S. Army Medical Research and Development Command